$ABT news
The latest ABT stock news: headlines, filings, AI summaries and sentiment for $ABT, updated around the clock.
- ABBOTT LABORATORIES - 10-Q Filing
- AbbVie Reports Strong Third Quarter Growth Driven by Skyrizi and Rinvoq
- Boston Scientific Shares Fall After Cyberattack Impacts Sales and Earnings Guidance
- Abbott Laboratories Announces Third-Quarter Results and Plan to Spin Off Nutrition Segment
- Abbott Announces Nutrition Business Spin-off to Focus on High-Margin Medical Technologies
- Abbott Laboratories Reports Q3 2026 Growth Driven by Diagnostics and Medical Devices
- ABBOTT LABORATORIES - 8-K Filing
- Market Outlook: SpaceX Gains and Super Micro Beat Drive Futures While Netflix and Abbott Lag
- Abbott Laboratories Shares Decline Following Lowered 2026 Growth Outlook
- ABBOTT LABORATORIES - 8-K Filing
- Major Earnings Releases Scheduled Before Market Open on Wednesday
- Barclays Initiates Coverage with Overweight Ratings for Stryker and Abbott
- Abbott Launches SimpleScreen Blood Test for Colorectal Cancer Screening
- Abbott partners with Berry Street to offer nutrition coaching for Lingo users
- Abbott Laboratories and Intuitive Surgical: Revenue Growth Trends Highlight Stability vs. Expansion
- Wall Street's Growing Optimism Toward Abbott Laboratories
- Wall Street's Growing Optimism Toward Abbott Laboratories
- Boston Scientific Stock Falls Over Half Despite Rising Sales
- Medtronic Raises Fiscal Outlook Amid Strong Heart Device Demand
- $385 Million Settlement with Abbott Over Infant Formula Allegations
- Abbott Laboratories Agrees to $385 Million Settlement with DOJ Over Infant Formula Recall
- Boston Scientific Unlikely to Meet 2026 Sales, Profit Forecasts After Cyberattack
- Abbott Launches First FDA-Approved Dual-Monitoring Continuous Glucose Monitor
- Hackers claim millions of patient records stolen during data breach at McKesson
- Dexcom and Abbott Await Medicare Coverage Expansion for Continuous Glucose Monitors
- Boston Scientific Shares Drop Amid Cybersecurity Incident and Product Recall
- Schwab U.S. Dividend Equity ETF (SCHD) Gains $679M Amid Strong Performance
- Schwab U.S. Dividend Equity ETF (SCHD) Sees $679M Inflows Amid Strong Performance
- Ken Griffin Increases Stake in AbbVie and Abbott Laboratories
- Amgen Faces Data Breach Affecting Patient Information
- Matrix Asset Advisors' Large Cap Value Portfolio Adds ABT and MCD; Exits NSRGY
- Amgen Discloses Cybersecurity Incident Involving Patient Health Data
- GE HealthCare Exceeds Quarterly Profit Estimates Amid Strong Imaging Demand and Tariff Refunds
- Abbott Raises Profit Forecast Amid Strong Performance from Diagnostics and Medical Devices
- ABBOTT LABORATORIES - 10-Q Filing
- ACA Coverage Changes Pose $50 Billion Challenge for Intuitive Surgical
- Tempus Agrees to Acquire Cancer Test Maker Personalis for $1.5 Billion
- Johnson & Johnson vs Abbott Laboratories: Diverging Strategic Paths in Healthcare
- Intuitive Surgical shares fall amid concerns over insurance plan changes impacting medtech demand
- Abbott Laboratories Raises Full-Year Profit Forecast After Strong Q2 Results
- Micron Shares Drop Amid Extended Tech Sell-Off on July 16
- Abbott Reallocates Capital Toward High-Margin MedTech and Diagnostics
- Abbott Raises 2026 Profit Forecast Due to Strong Performance in Diagnostics and Heart Devices
- Nasdaq and Major Indexes Drop as AI Spending Concerns Weigh on Chip Stocks
- Meta Poised to Hire Key AWS Executive Amid AI Talent War; Cramer Offers Market Insights
- AI Stocks Decline, Weighing on Global Markets
- Abbott Laboratories Stock Rises on Strong Q2 Results and Raised Earnings Outlook
- Micron Shares Drop Amid Tech Stock Sell-Off on July 16
- Nasdaq Rises on Apple Gains and Softer PPI Data
- Abbott Laboratories Shares Rise Over 10% After Strong Q2 Earnings Report